Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition

Epithelial to mesenchymal transition (EMT) has implications in tumor progression and metastasis. Metabolic alterations have been described in cancer development but studies focused on the metabolic re-wiring that takes place during EMT are still limited. We performed metabolomics profiling of a brea...

Full description

Saved in:
Bibliographic Details
Published inCancer letters Vol. 396; pp. 117 - 129
Main Authors Halldorsson, Skarphedinn, Rohatgi, Neha, Magnusdottir, Manuela, Choudhary, Kumari Sonal, Gudjonsson, Thorarinn, Knutsen, Erik, Barkovskaya, Anna, Hilmarsdottir, Bylgja, Perander, Maria, Mælandsmo, Gunhild M., Gudmundsson, Steinn, Rolfsson, Óttar
Format Journal Article
LanguageEnglish
Published Ireland Elsevier B.V 28.06.2017
Elsevier Limited
Elsevier
Subjects
Online AccessGet full text
ISSN0304-3835
1872-7980
1872-7980
DOI10.1016/j.canlet.2017.03.019

Cover

More Information
Summary:Epithelial to mesenchymal transition (EMT) has implications in tumor progression and metastasis. Metabolic alterations have been described in cancer development but studies focused on the metabolic re-wiring that takes place during EMT are still limited. We performed metabolomics profiling of a breast epithelial cell line and its EMT derived mesenchymal phenotype to create genome-scale metabolic models descriptive of both cell lines. Glycolysis and OXPHOS were higher in the epithelial phenotype while amino acid anaplerosis and fatty acid oxidation fueled the mesenchymal phenotype. Through comparative bioinformatics analysis, PPAR-γ1, PPAR- γ2 and AP-1 were found to be the most influential transcription factors associated with metabolic re-wiring. In silico gene essentiality analysis predicts that the LAT1 neutral amino acid transporter is essential for mesenchymal cell survival. Our results define metabolic traits that distinguish an EMT derived mesenchymal cell line from its epithelial progenitor and may have implications in cancer progression and metastasis. Furthermore, the tools presented here can aid in identifying critical metabolic nodes that may serve as therapeutic targets aiming to prevent EMT and inhibit metastatic dissemination.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Cancer Letters
ISSN:0304-3835
1872-7980
1872-7980
DOI:10.1016/j.canlet.2017.03.019